The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course during long term treatment in the usual clinical setting, in drug addicts. The plasma levels of naltrexone and 6-b-naltrexol were determined for 24 hours following an oral dose of 100 mg at the beginning and after months of naltrexone treatment. Our results showed large differences among patients in serum naltrexone and 6b-naltrexol levels. On the other hand, there were no differences in serum time course of both substances in the same patient over 3 months. Peak levels and AUCs of naltrexone were lower than those of 6b-naltrexol in 10 addicts and higher than those of the metabolite in 3 patients. No significant differences in the apparent h...
Abstract Background Naltrexone has been proven to be an effective treatment option for the treatment...
Naltrexone, a mu opioid receptor antagonist, is used in the treatment of opioid and alcohol dependen...
In liver cirrhosis significant changes in the serum levels of naltrexone and 6-beta-naltrexolare are...
The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course du...
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment ...
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment ...
The aim of this study was to profile and compare blood naltrexone and 6-β-naltrexol levels with time...
The time-course of naltrexone and 6-beta-naltrexol did not change after month of naltrexone treatmen...
Naltrexone is a competitive opiate antagonist with high hepatic extraction. It is used for detoxific...
Naltrexone is a competitive opiate antagonist with high hepatic extraction. It is used for detoxific...
BACKGROUND/AIMS: Naltrexone has been proposed as a possible treatment of pruritus in cholestasis.The...
liver cirrhosis induces important changes in the time-course of naltrexone with higher bioavailabili...
liver cirrhosis induces important changes in the time-course of naltrexone with higher bioavailabili...
The aim of this study was to assess blood free naltrexone and 6-β-naltrexol levels with time followi...
6β-Naltrexol is the major human metabolite of naltrexone, which is an opioid receptor antagonist use...
Abstract Background Naltrexone has been proven to be an effective treatment option for the treatment...
Naltrexone, a mu opioid receptor antagonist, is used in the treatment of opioid and alcohol dependen...
In liver cirrhosis significant changes in the serum levels of naltrexone and 6-beta-naltrexolare are...
The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course du...
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment ...
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment ...
The aim of this study was to profile and compare blood naltrexone and 6-β-naltrexol levels with time...
The time-course of naltrexone and 6-beta-naltrexol did not change after month of naltrexone treatmen...
Naltrexone is a competitive opiate antagonist with high hepatic extraction. It is used for detoxific...
Naltrexone is a competitive opiate antagonist with high hepatic extraction. It is used for detoxific...
BACKGROUND/AIMS: Naltrexone has been proposed as a possible treatment of pruritus in cholestasis.The...
liver cirrhosis induces important changes in the time-course of naltrexone with higher bioavailabili...
liver cirrhosis induces important changes in the time-course of naltrexone with higher bioavailabili...
The aim of this study was to assess blood free naltrexone and 6-β-naltrexol levels with time followi...
6β-Naltrexol is the major human metabolite of naltrexone, which is an opioid receptor antagonist use...
Abstract Background Naltrexone has been proven to be an effective treatment option for the treatment...
Naltrexone, a mu opioid receptor antagonist, is used in the treatment of opioid and alcohol dependen...
In liver cirrhosis significant changes in the serum levels of naltrexone and 6-beta-naltrexolare are...